Ellen van der Plas, Ph.D. and researchers at the Arkansas Children’s Research Institute took part in a nationwide, multi-center trial to examine the risk factors for neurocognitive impairment, emotional distress and poor quality of life in survivors of pediatric rhabdomyosarcoma. Read about their findings here. Read the findings on PubMed.
ACRI
Arkansas Children’s Research Institute Research Week
The inaugural ACRI Research Week was held May 15-19, 2023. UAMS pediatric residents had the opportunity to share their research during the ACRI Poster Symposium and network with the amazing researchers we have on campus! The invited scholar, Dr. Ashish Kumar gave an engaging and informative presentation on BRAF to the Future: Targeted Therapies for Histiocytic […]
Peanut Allergy Trial Includes Peds Faculty and ACRI
Dr. Stacie Jones is a co-author and site primary investigator (PI) at the Arkansas Children’s Research Institute (ACRI) for a phase 3 trial of epicutaneous immunotherapy in toddlers with peanut allergy. The abstract for the findings states, “No approved treatment for peanut allergy exists for children younger than 4 years of age, and the efficacy […]